What is the main purpose of the By-Laws amendment reported in this 8-K?

The primary purpose of the amendment is to increase transparency regarding shareholders who wish to nominate directors or present proposals at annual meetings. It requires these shareholders to disclose any hedging activities or transactions that could affect their economic interest or voting power concerning WellPoint's (Elevance Health's) stock.

Who is required to provide this additional disclosure?

Any shareholder intending to submit a nomination for election to the Board of Directors or a shareholder proposal for consideration at an annual meeting of shareholders is now required to provide this disclosure.

What specific types of transactions need to be disclosed?

Shareholders must disclose whether they have hedged their ownership of the company's securities or entered into any transaction that has the effect of increasing or decreasing their economic risk or voting power with respect to the company's securities.

When did these amendments become effective?

The amendments to the By-Laws took effect immediately upon adoption by the Board of Directors on May 21, 2008.

ELV 8-K: Corporate Changes

Summary

Elevance Health, Inc. (operating as WellPoint, Inc. at the time of this filing) filed an 8-K report on May 22, 2008, to announce amendments to its By-Laws. These amendments, adopted by the Board of Directors on May 21, 2008, primarily impact the advance notice provisions for shareholder nominations and proposals. The key change requires shareholders intending to nominate a director or submit a proposal for consideration at an annual meeting to disclose any hedging activities or transactions that affect their economic risk or voting power related to the company's securities. This aims to provide greater transparency regarding shareholder intentions and potential conflicts or influence.

Key Highlights

1WellPoint, Inc. (now Elevance Health) amended its By-Laws on May 21, 2008.
2The amendments focus on enhancing disclosure requirements for shareholder nominations and proposals.
3Shareholders must now disclose hedging activities or transactions affecting economic risk/voting power for the company's securities.
4These changes apply to nominations for the Board of Directors and shareholder proposals for annual meetings.
5The amendments were adopted by the Board of Directors upon recommendation of the Governance Committee.
6The effective date of the amendments was upon adoption by the Board.
7The filing also includes an exhibit of the amended By-Laws.

Elevance Health, Inc. 8-K Report, Bylaw Amendment (May 22, 2008)

Summary

Key Highlights

Frequently Asked Questions